{
  "id": "prt_958c9b1e9001PdXYwxcIsg2Ev3",
  "messageID": "msg_958c9989a001fyNQ3xqeHEqauc",
  "sessionID": "ses_6a7af0913ffePKeafEVjU8Zw0Y",
  "type": "tool",
  "tool": "read",
  "callID": "toolu_01BZPRKYUtFDXvaJ7PVtdDTb",
  "state": {
    "status": "completed",
    "input": {
      "filePath": "/home/user/project/lib/translations/en.ts"
    },
    "output": "<file>\n00001| import { Translation } from './types'\n00002| \n00003| export const en: Translation = {\n00004|   app: {\n00005|     title: 'AutoDx: ME/CFS · Long COVID · POTS',\n00006|     subtitle: 'A guided, guideline-based diagnostic engine and decision support tool for clinicians treating patients with fatigue, dizziness, brain-fog, or palpitations.',\n00007|     tagline: 'Making invisible diseases visible - with evidence, empathy and code.',\n00008|     backToDashboard: 'Back to Dashboard'\n00009|   },\n00010| \n00011|   common: {\n00012|     yes: 'Yes',\n00013|     no: 'No',\n00014|     next: 'Next',\n00015|     previous: 'Previous',\n00016|     continue: 'Continue',\n00017|     complete: 'Complete',\n00018|     cancel: 'Cancel',\n00019|     save: 'Save',\n00020|     download: 'Download',\n00021|     loading: 'Loading',\n00022|     processing: 'Processing',\n00023|     error: 'Error',\n00024|     success: 'Success',\n00025|     retry: 'Retry',\n00026|     close: 'Close',\n00027|     age: 'Age',\n00028|     gender: 'Gender',\n00029|     male: 'Male',\n00030|     female: 'Female',\n00031|     other: 'Other',\n00032|     question: 'Question',\n00033|     of: 'of',\n00034|     step: 'Step',\n00035|     minute: 'minute',\n00036|     minutes: 'minutes',\n00037|     bpm: 'bpm',\n00038|     criteria: 'Criteria',\n00039|     met: 'Met',\n00040|     notMet: 'Not Met',\n00041|     high: 'High',\n00042|     medium: 'Medium',\n00043|     low: 'Low',\n00044|     none: 'None',\n00045|     mild: 'Mild',\n00046|     moderate: 'Moderate',\n00047|     severe: 'Severe',\n00048|     confidence: 'Confidence',\n00049|     sensitivity: 'Sensitivity',\n00050|     score: 'Score',\n00051|     results: 'Results',\n00052|     recommendations: 'Recommendations',\n00053|     clinician: 'Clinician',\n00054|     patientId: 'Patient ID',\n00055|     required: 'Required',\n00056|     optional: 'Optional'\n00057|   },\n00058| \n00059|   dashboard: {\n00060|     smartAssessment: {\n00061|       title: 'Smart Patient Assessment',\n00062|       description: 'Intelligent guided workflow with automated SOAP documentation',\n00063|       autoRouting: 'Auto-routing',\n00064|       soapNotes: 'SOAP notes',\n00065|       icdCodes: 'ICD-10 codes',\n00066|       startNew: 'Start New Assessment'\n00067|     },\n00068|     modules: {\n00069|       quickScreen: {\n00070|         title: 'Quick-Screen',\n00071|         description: '16 yes/no questions - 2 min assessment'\n00072|       },\n00073|       redFlag: {\n00074|         title: 'Red-flag Checker',\n00075|         description: 'Lab suggestions to rule out explanatory disease'\n00076|       },\n00077|       standTest: {\n00078|         title: 'Stand-Test Pro',\n00079|         description: '10-min NASA Lean protocol with HR monitoring'\n00080|       },\n00081|       pemQuest: {\n00082|         title: 'PEM-Quest',\n00083|         description: 'Post-Exertional Malaise assessment'\n00084|       },\n00085|       criteriaEngine: {\n00086|         title: 'Criteria Engine',\n00087|         description: 'CDC, IOM, ESC, WHO guidelines with ICD-10 codes'\n00088|       },\n00089|       subtypeAdvisor: {\n00090|         title: 'Subtype & Rx Advisor',\n00091|         description: 'Personalized treatment recommendations'\n00092|       }\n00093|     },\n00094|     stats: {\n00095|       diagnosticDelay: '4-5 year avg diagnostic delay',\n00096|       doctorsConsulted: '≥7 doctors typically consulted',\n00097|       sensitivityValidated: '94% sensitivity validated'\n00098|     },\n00099|     algorithm: {\n00100|       title: 'Diagnostic Algorithm',\n00101|       mecfs: {\n00102|         title: 'ME/CFS',\n00103|         criteria: 'CDC/NASEM 2015 + IOM criteria',\n00104|         description: '3 core + 1 PEM symptom cluster'\n00105|       },\n00106|       longCovid: {\n00107|         title: 'Long COVID',\n00108|         criteria: 'WHO + NASEM 2024 criteria',\n00109|         description: '≥3 months post-SARS-CoV-2'\n00110|       },\n00111|       pots: {\n00112|         title: 'POTS',\n00113|         criteria: 'ESC 2018 + AAS/EFAS 2021',\n00114|         description: 'HR↑≥30 bpm within 10 min'\n00115|       }\n00116|     },\n00117|     startAssessment: 'Start Assessment'\n00118|   },\n00119| \n00120|   quickScreen: {\n00121|     title: 'Quick-Screen Assessment',\n00122|     description: '16 questions · ~2 minutes · 92% sensitivity',\n00123|     questions: [\n00124|       'Do you experience severe fatigue that is not relieved by rest?',\n00125|       'Does physical or mental activity make your symptoms worse (Post-Exertional Malaise)?',\n00126|       'Do you have unrefreshing sleep, regardless of duration?',\n00127|       'Do you experience cognitive difficulties (brain fog, memory problems)?',\n00128|       'Do you have palpitations or rapid heart rate, especially when standing?',\n00129|       'Do you experience dizziness or lightheadedness when standing up?',\n00130|       'Have you had COVID-19 or suspected COVID-19 infection?',\n00131|       'Have your symptoms persisted for 3 months or longer?',\n00132|       'Do you experience muscle pain or joint pain without swelling?',\n00133|       'Do you have frequent headaches or changes in headache patterns?',\n00134|       'Do you experience temperature dysregulation (feeling too hot/cold)?',\n00135|       'Do you have gastrointestinal symptoms (nausea, bloating, changes in bowel habits)?',\n00136|       'Do you experience shortness of breath or breathing difficulties?',\n00137|       'Have you noticed decreased exercise tolerance or physical capacity?',\n00138|       'Do you experience sensitivity to light, sound, or touch?',\n00139|       'Have you been unable to maintain your previous level of activity?'\n00140|     ],\n00141|     categories: {\n00142|       core: 'Core',\n00143|       pem: 'PEM',\n00144|       cardiovascular: 'Cardiovascular',\n00145|       orthostatic: 'Orthostatic',\n00146|       history: 'History',\n00147|       duration: 'Duration',\n00148|       pain: 'Pain',\n00149|       neurological: 'Neurological',\n00150|       autonomic: 'Autonomic',\n00151|       gi: 'GI',\n00152|       respiratory: 'Respiratory',\n00153|       functional: 'Functional',\n00154|       sensory: 'Sensory'\n00155|     },\n00156|     results: {\n00157|       complete: 'Screening Complete',\n00158|       riskAssessment: 'Based on your responses, here\\'s your risk assessment',\n00159|       lowRisk: 'Low Risk for ME/CFS, Long COVID, or POTS',\n00160|       mediumRisk: 'Medium Risk for ME/CFS, Long COVID, or POTS',\n00161|       highRisk: 'High Risk for ME/CFS, Long COVID, or POTS',\n00162|       totalResponses: 'Total positive responses',\n00163|       coreSymptoms: 'Core symptoms present',\n00164|       pemPresent: 'Post-exertional malaise',\n00165|       covidHistory: 'COVID history',\n00166|       chronicSymptoms: 'Chronic symptoms (≥3 months)',\n00167|       nextSteps: 'Next Steps',\n00168|       retake: 'Retake Screening'\n00169|     },\n00170|     nextStepsRecommendations: {\n00171|       high: [\n00172|         'Proceed to Red-flag Checker',\n00173|         'Complete Stand-Test Pro',\n00174|         'Consider PEM-Quest assessment'\n00175|       ],\n00176|       medium: [\n00177|         'Consider Red-flag Checker',\n00178|         'Monitor symptoms closely',\n00179|         'Follow-up in 4-6 weeks'\n00180|       ],\n00181|       low: [\n00182|         'Routine clinical assessment',\n00183|         'Consider other diagnoses',\n00184|         'Reassess if symptoms worsen'\n00185|       ]\n00186|     }\n00187|   },\n00188| \n00189|   redFlag: {\n00190|     title: 'Red-flag Checker',\n00191|     description: 'Identify symptoms requiring urgent evaluation and rule out explanatory diseases',\n00192|     symptoms: {\n00193|       title: 'Red Flag Symptoms',\n00194|       description: 'Check any symptoms present that may require urgent evaluation',\n00195|       list: [\n00196|         'Persistent fever or night sweats',\n00197|         'Unintentional weight loss >10% in 6 months',\n00198|         'Chest pain with exertion or at rest',\n00199|         'Progressive shortness of breath',\n00200|         'New neurological symptoms (weakness, numbness, seizures)',\n00201|         'Abnormal bleeding or bruising',\n00202|         'Enlarged lymph nodes',\n00203|         'Jaundice or yellowing of skin/eyes'\n00204|       ]\n00205|     },\n00206|     routineLabs: {\n00207|       title: 'Routine Screening Labs',\n00208|       description: 'Select categories of tests to rule out common explanatory conditions',\n00209|       categories: {\n00210|         basicMetabolic: {\n00211|           title: 'Basic Metabolic',\n00212|           indication: 'Rule out anemia, infection, inflammation, electrolyte abnormalities',\n00213|           tests: ['CBC with differential', 'Comprehensive metabolic panel', 'ESR', 'CRP']\n00214|         },\n00215|         endocrine: {\n00216|           title: 'Endocrine',\n00217|           indication: 'Rule out thyroid dysfunction, diabetes, adrenal insufficiency',\n00218|           tests: ['TSH', 'Free T4', 'HbA1c', 'Cortisol (AM)', 'Vitamin D']\n00219|         },\n00220|         nutritional: {\n00221|           title: 'Nutritional',\n00222|           indication: 'Rule out nutritional deficiencies causing fatigue',\n00223|           tests: ['Vitamin B12', 'Folate', 'Iron studies', 'Ferritin']\n00224|         },\n00225|         autoimmune: {\n00226|           title: 'Autoimmune',\n00227|           indication: 'Screen for autoimmune conditions',\n00228|           tests: ['ANA', 'RF', 'Anti-CCP', 'Celiac antibodies']\n00229|         },\n00230|         cardiac: {\n00231|           title: 'Cardiac',\n00232|           indication: 'Rule out structural heart disease, heart failure',\n00233|           tests: ['ECG', 'Echocardiogram', 'BNP/NT-proBNP']\n00234|         },\n00235|         infectious: {\n00236|           title: 'Infectious',\n00237|           indication: 'Rule out chronic infections',\n00238|           tests: ['Hepatitis B/C', 'HIV', 'Lyme antibodies', 'CMV/EBV antibodies']\n00239|         }\n00240|       }\n00241|     },\n00242|     results: {\n00243|       complete: 'Red-flag Assessment Complete',\n00244|       urgentEval: 'Urgent Evaluation Required',\n00245|       priorityTests: 'Priority Tests (Red Flags)',\n00246|       routineTests: 'Routine Screening Tests',\n00247|       noRedFlags: 'No Red Flags Identified',\n00248|       clinicalSupport: 'Clinical Decision Support',\n00249|       urgent: 'Expedite workup due to high-priority red flags. Consider same-day or next-day evaluation. Hold off on ME/CFS/POTS assessment until red flags ruled out.',\n00250|       priority: 'Complete recommended tests within 1-2 weeks. Can proceed with stand-test if cardiovascular red flags absent. Re-evaluate based on test results.',\n00251|       routine: 'Proceed with routine screening labs. Can continue with ME/CFS/Long COVID/POTS assessment. Consider 4-6 week follow-up for test results.',\n00252|       reassess: 'Reassess',\n00253|       generateRecommendations: 'Generate Recommendations'\n00254|     }\n00255|   },\n00256| \n00257|   standTest: {\n00258|     title: 'Stand-Test Pro',\n00259|     description: 'NASA Lean Stand Test Protocol - 10 minute heart rate monitoring',\n00260|     setup: {\n00261|       title: 'Test Setup',\n00262|       description: 'Choose your preferred method for heart rate monitoring',\n00263|       manual: {\n00264|         title: 'Manual Entry',\n00265|         description: 'Use pulse oximeter, fitness tracker, or manual pulse counting',\n00266|         recommended: 'Recommended'\n00267|       },\n00268|       camera: {\n00269|         title: 'Camera PPG',\n00270|         description: 'Use device camera for photoplethysmography (experimental)',\n00271|         beta: 'Beta Feature'\n00272|       },\n00273|       safety: 'Safety Note: Stop the test immediately if you experience chest pain, severe dizziness, or feel faint. Have a chair nearby for safety.',\n00274|       startTest: 'Start Stand Test'\n00275|     },\n00276|     phases: {\n00277|       baseline: {\n00278|         name: 'Baseline Lying',\n00279|         instructions: 'Lie down comfortably and remain still. Breathe normally and relax.'\n00280|       },\n00281|       standing: {\n00282|         name: 'Standing Phase',\n00283|         instructions: 'Stand up quickly and remain standing. Do not lean against walls or move around.'\n00284|       }\n00285|     },\n00286|     recording: {\n00287|       title: 'Record Heart Rate',\n00288|       description: 'Enter current heart rate reading (record every 1-2 minutes)',\n00289|       baselineHR: 'Baseline HR (lying down)',\n00290|       peakHR: 'Peak Standing HR',\n00291|       systolicBP: 'Systolic BP (optional)',\n00292|       diastolicBP: 'Diastolic BP (optional)',\n00293|       recordReading: 'Record Reading',\n00294|       recentReadings: 'Recent Readings'\n00295|     },\n00296|     results: {\n00297|       title: 'Stand-Test Results',\n00298|       description: 'NASA Lean Stand Test Results - 10 minute protocol',\n00299|       baseline: 'Baseline (Lying)',\n00300|       peakStanding: 'Peak Standing',\n00301|       sustainedStanding: 'Sustained Standing',\n00302|       averageHR: 'Average heart rate',\n00303|       maxHR: 'Maximum heart rate',\n00304|       hrIncrease: 'HR Increase',\n00305|       potsCriteria: 'POTS Criteria',\n00306|       potsMet: 'POTS Criteria Met',\n00307|       potsNotMet: 'POTS Criteria Not Met',\n00308|       interpretation: 'Clinical Interpretation',\n00309|       nextSteps: 'Next Steps',\n00310|       repeatTest: 'Repeat Test'\n00311|     },\n00312|     interpretations: {\n00313|       potsMet: [\n00314|         'Heart rate increase suggests orthostatic intolerance consistent with POTS',\n00315|         'Proceed to POTS subtyping for targeted treatment recommendations',\n00316|         'Consider additional autonomic testing if clinically indicated',\n00317|         'Rule out secondary causes (dehydration, medications, other conditions)'\n00318|       ],\n00319|       potsNotMet: [\n00320|         'Normal orthostatic heart rate response',\n00321|         'POTS unlikely based on current criteria',\n00322|         'Consider other causes of symptoms (ME/CFS, Long COVID without POTS)',\n00323|         'Repeat testing if symptoms persist or worsen'\n00324|       ]\n00325|     },\n00326|     controls: {\n00327|       pause: 'Pause',\n00328|       resume: 'Resume',\n00329|       stop: 'Stop Test'\n00330|     }\n00331|   },\n00332| \n00333|   pem: {\n00334|     title: 'PEM-Quest Assessment',\n00335|     description: 'Post-Exertional Malaise evaluation - 5 validated questions',\n00336|     about: {\n00337|       title: 'About Post-Exertional Malaise (PEM)',\n00338|       description: 'PEM is the worsening of symptoms following physical or mental activity that was previously tolerated. It\\'s a key feature of ME/CFS and often occurs in Long COVID. Symptoms may be delayed and can last days to weeks.'\n00339|     },\n00340|     questions: {\n00341|       frequency: {\n00342|         question: 'How often do you experience a worsening of symptoms following physical activity?',\n00343|         description: 'Consider activities like walking, climbing stairs, or household chores',\n00344|         options: [\n00345|           'Never',\n00346|           'Rarely (less than 25% of the time)',\n00347|           'Sometimes (25-50% of the time)',\n00348|           'Often (50-75% of the time)',\n00349|           'Always or almost always (more than 75% of the time)'\n00350|         ]\n00351|       },\n00352|       mentalFrequency: {\n00353|         question: 'How often do you experience a worsening of symptoms following mental activity?',\n00354|         description: 'Consider activities like reading, concentrating, or problem-solving',\n00355|         options: [\n00356|           'Never',\n00357|           'Rarely (less than 25% of the time)',\n00358|           'Sometimes (25-50% of the time)',\n00359|           'Often (50-75% of the time)',\n00360|           'Always or almost always (more than 75% of the time)'\n00361|         ]\n00362|       },\n00363|       onsetTime: {\n00364|         question: 'How soon after activity do your symptoms typically worsen?',\n00365|         options: [\n00366|           'No worsening occurs',\n00367|           'During the activity',\n00368|           'Immediately after (within 30 minutes)',\n00369|           'Within a few hours (2-6 hours)',\n00370|           'The next day or later'\n00371|         ]\n00372|       },\n00373|       severity: {\n00374|         question: 'How severe is the worsening of your symptoms after activity?',\n00375|         options: [\n00376|           'No worsening',\n00377|           'Mild - slightly worse than before activity',\n00378|           'Moderate - noticeably worse, but manageable',\n00379|           'Severe - significantly worse, difficult to function',\n00380|           'Very severe - unable to function, bedridden'\n00381|         ]\n00382|       },\n00383|       recoveryTime: {\n00384|         question: 'How long does it typically take for your symptoms to return to baseline after activity?',\n00385|         options: [\n00386|           'No recovery time needed',\n00387|           'A few hours',\n00388|           'About one day',\n00389|           'Several days (2-6 days)',\n00390|           'A week or more'\n00391|         ]\n00392|       }\n00393|     },\n00394|     results: {\n00395|       complete: 'PEM Assessment Complete',\n00396|       description: 'Post-Exertional Malaise evaluation based on DePaul criteria',\n00397|       status: 'PEM Status',\n00398|       present: 'Post-Exertional Malaise is likely present',\n00399|       absent: 'Post-Exertional Malaise is unlikely',\n00400|       severityLevels: {\n00401|         none: 'None',\n00402|         mild: 'Mild PEM',\n00403|         moderate: 'Moderate PEM',\n00404|         severe: 'Severe PEM'\n00405|       },\n00406|       clinicalInterpretation: 'Clinical Interpretation',\n00407|       recommendations: {\n00408|         severe: [\n00409|           'Strict activity pacing essential',\n00410|           'Consider disability evaluation',\n00411|           'Specialist ME/CFS clinic referral'\n00412|         ],\n00413|         moderate: [\n00414|           'Implement careful activity pacing',\n00415|           'Monitor for symptom progression',\n00416|           'Consider occupational therapy'\n00417|         ],\n00418|         mild: [\n00419|           'Begin gentle activity pacing',\n00420|           'Education on PEM recognition',\n00421|           'Regular symptom monitoring'\n00422|         ],\n00423|         none: [\n00424|           'PEM not significantly present',\n00425|           'Consider other diagnoses',\n00426|           'Standard activity as tolerated'\n00427|         ]\n00428|       },\n00429|       important: 'Important: PEM is the hallmark symptom of ME/CFS. If present, avoid activities that consistently trigger symptom worsening. Energy management and pacing are key treatment strategies.',\n00430|       retake: 'Retake Assessment'\n00431|     }\n00432|   },\n00433| \n00434|   criteria: {\n00435|     title: 'Criteria Engine',\n00436|     description: 'Apply CDC, NASEM, ESC, WHO diagnostic criteria for final determination',\n00437|     mecfs: {\n00438|       title: 'ME/CFS Criteria (CDC/NASEM 2015)',\n00439|       description: 'Requires substantial fatigue, PEM, unrefreshing sleep, AND either cognitive impairment OR orthostatic intolerance',\n00440|       criteria: [\n00441|         'Substantial reduction or impairment in activity levels that persists for ≥6 months',\n00442|         'Post-exertional malaise (PEM) present',\n00443|         'Unrefreshing sleep',\n00444|         'Cognitive impairment (brain fog)',\n00445|         'Orthostatic intolerance OR autonomic dysfunction'\n00446|       ]\n00447|     },\n00448|     longCovid: {\n00449|       title: 'Long COVID Criteria (WHO/NASEM 2024)',\n00450|       description: 'Post-acute sequelae of SARS-CoV-2 infection with persistent multi-system symptoms',\n00451|       criteria: [\n00452|         'Confirmed or probable SARS-CoV-2 infection',\n00453|         'Symptoms persist ≥3 months from acute illness',\n00454|         'Multi-system symptoms affecting daily functioning',\n00455|         'Symptoms not explained by alternative diagnosis'\n00456|       ],\n00457|       timing: {\n00458|         confirmed: 'Confirmed by test',\n00459|         probable: 'Probable based on symptoms/exposure',\n00460|         suspected: 'Suspected based on timing'\n00461|       }\n00462|     },\n00463|     pots: {\n00464|       title: 'POTS Criteria (ESC 2018/AAS-EFAS 2021)',\n00465|       description: 'Heart rate increase ≥30 bpm within 10 minutes of standing, with symptoms but without orthostatic hypotension',\n00466|       criteria: [\n00467|         'Heart rate increase ≥30 bpm within 10 minutes of standing',\n00468|         'Sustained heart rate ≥120 bpm while standing',\n00469|         'Orthostatic symptoms (dizziness, palpitations, fatigue)',\n00470|         'Symptoms present for ≥3 months',\n00471|         'Absence of orthostatic hypotension'\n00472|       ]\n00473|     },\n00474|     results: {\n00475|       complete: 'Diagnostic Criteria Assessment Complete',\n00476|       description: 'Based on CDC, NASEM, ESC, WHO guidelines',\n00477|       diagnosesMet: 'Diagnoses Meeting Criteria',\n00478|       criteriaMet: 'CRITERIA MET',\n00479|       clinicalRecommendations: 'Clinical Recommendations',\n00480|       mecfsManagement: [\n00481|         'Implement activity pacing and energy management',\n00482|         'Avoid graded exercise therapy (GET)',\n00483|         'Consider symptom-directed treatments',\n00484|         'Specialist ME/CFS clinic referral if available'\n00485|       ],\n00486|       longCovidManagement: [\n00487|         'Multidisciplinary approach to symptom management',\n00488|         'Long COVID clinic referral if available',\n00489|         'Monitor for improvement over time',\n00490|         'Address individual symptoms (fatigue, cognitive, respiratory)'\n00491|       ],\n00492|       potsManagement: [\n00493|         'Proceed to subtype determination for targeted therapy',\n00494|         'Non-pharmacological: salt, fluids, compression garments',\n00495|         'Consider cardiology or autonomic specialist referral',\n00496|         'Gradual exercise reconditioning when appropriate'\n00497|       ],\n00498|       reassess: 'Reassess Criteria',\n00499|       downloadReport: 'Download Report',\n00500|       potsSubtype: 'POTS Subtype Analysis'\n00501|     }\n00502|   },\n00503| \n00504|   subtype: {\n00505|     title: 'POTS Subtype & Treatment Advisor',\n00506|     description: 'Determine POTS subtype for personalized treatment recommendations',\n00507|     patientInfo: {\n00508|       title: 'Patient Information',\n00509|       description: 'Basic patient details for treatment planning',\n00510|       comorbidities: 'Relevant Comorbidities (check all that apply)'\n00511|     },\n00512|     subtypes: {\n00513|       hypovolemic: {\n00514|         name: 'Hypovolemic POTS',\n00515|         description: 'Low blood volume causing orthostatic intolerance',\n00516|         criteria: [\n00517|           'Low-normal blood pressure (<110/70)',\n00518|           'Excessive thirst',\n00519|           'Salt craving',\n00520|           'Signs of volume depletion',\n00521|           'Elevated renin/aldosterone (if available)'\n00522|         ],\n00523|         treatments: {\n00524|           nonPharmacological: [\n00525|             'Increase fluid intake to 2.5-3L daily',\n00526|             'Increase sodium intake to 8-10g daily',\n00527|             'Compression garments (30-40 mmHg)',\n00528|             'Gradual exercise reconditioning'\n00529|           ],\n00530|           firstLine: [\n00531|             'Fludrocortisone 0.1-0.2mg daily',\n00532|             'Salt tablets if dietary intake insufficient'\n00533|           ],\n00534|           secondLine: [\n00535|             'Desmopressin (DDAVP) for severe cases',\n00536|             'Erythropoietin if anemic'\n00537|           ]\n00538|         }\n00539|       },\n00540|       neuropathic: {\n00541|         name: 'Neuropathic POTS',\n00542|         description: 'Peripheral autonomic neuropathy affecting blood vessel control',\n00543|         criteria: [\n00544|           'Distal small fiber neuropathy symptoms',\n00545|           'GI dysfunction (gastroparesis, constipation)',\n00546|           'Anhidrosis or reduced sweating',\n00547|           'Pupillary abnormalities',\n00548|           'History of diabetes or autoimmune disease'\n00549|         ],\n00550|         treatments: {\n00551|           nonPharmacological: [\n00552|             'Compression garments',\n00553|             'Leg elevation',\n00554|             'Avoid heat exposure',\n00555|             'Small frequent meals'\n00556|           ],\n00557|           firstLine: [\n00558|             'Midodrine 2.5-10mg TID',\n00559|             'Pyridostigmine 30-60mg TID'\n00560|           ],\n00561|           secondLine: [\n00562|             'Droxidopa (if available)',\n00563|             'Alpha-lipoic acid for neuropathy',\n00564|             'IVIG for autoimmune cases'\n00565|           ]\n00566|         }\n00567|       },\n00568|       hyperadrenergic: {\n00569|         name: 'Hyperadrenergic POTS',\n00570|         description: 'Excessive sympathetic nervous system activation',\n00571|         criteria: [\n00572|           'Hypertension when standing',\n00573|           'Anxiety, panic attacks, tremor',\n00574|           'Migraine headaches',\n00575|           'Cold hands and feet',\n00576|           'Elevated standing norepinephrine >600 pg/mL'\n00577|         ],\n00578|         treatments: {\n00579|           nonPharmacological: [\n00580|             'Stress reduction techniques',\n00581|             'Avoid stimulants (caffeine)',\n00582|             'Regular sleep schedule',\n00583|             'Gentle exercise'\n00584|           ],\n00585|           firstLine: [\n00586|             'Propranolol 10-40mg BID',\n00587|             'Clonidine 0.1-0.2mg BID'\n00588|           ],\n00589|           secondLine: [\n00590|             'Ivabradine 2.5-7.5mg BID',\n00591|             'Methyldopa',\n00592|             'Labetalol for hypertension'\n00593|           ]\n00594|         }\n00595|       },\n00596|       autoimmune: {\n00597|         name: 'Autoimmune POTS',\n00598|         description: 'Autoimmune-mediated autonomic dysfunction',\n00599|         criteria: [\n00600|           'Personal/family history of autoimmune disease',\n00601|           'Rapid onset of symptoms',\n00602|           'Viral illness trigger (EBV, COVID, etc.)',\n00603|           'Positive autonomic antibodies (if tested)',\n00604|           'Other autoimmune markers positive'\n00605|         ],\n00606|         treatments: {\n00607|           nonPharmacological: [\n00608|             'Standard POTS measures',\n00609|             'Avoid infection triggers',\n00610|             'Stress management',\n00611|             'Anti-inflammatory diet'\n00612|           ],\n00613|           firstLine: [\n00614|             'Standard POTS medications',\n00615|             'Trial of corticosteroids'\n00616|           ],\n00617|           secondLine: [\n00618|             'IVIG therapy',\n00619|             'Immunosuppressive agents',\n00620|             'Plasmapheresis for severe cases'\n00621|           ]\n00622|         }\n00623|       }\n00624|     },\n00625|     results: {\n00626|       complete: 'POTS Subtype Analysis Complete',\n00627|       description: 'Personalized treatment recommendations based on subtype assessment',\n00628|       primary: 'Primary',\n00629|       likelihood: 'likelihood',\n00630|       criteriaMetTitle: 'Criteria Met',\n00631|       allSubtypeScores: 'All Subtype Scores',\n00632|       nonPharmacological: 'Non-Pharmacological',\n00633|       firstLineRx: 'First-Line Rx',\n00634|       secondLineOptions: 'Second-Line Options',\n00635|       mixedSubtype: 'Mixed Subtype Considerations: This patient also shows features of multiple subtypes. Consider combination therapy approaches and monitor response to initial treatment.',\n00636|       clinicalPearls: 'Clinical Pearls',\n00637|       pearls: [\n00638|         'Start with non-pharmacological interventions for all POTS subtypes',\n00639|         'Begin medications at low doses and titrate slowly',\n00640|         'Monitor response and adjust treatment based on symptom improvement',\n00641|         'Consider specialist referral for complex cases or treatment failures',\n00642|         'Re-assess subtype if treatment response is poor'\n00643|       ],\n00644|       reassess: 'Reassess Subtype',\n00645|       downloadPlan: 'Download Treatment Plan'\n00646|     }\n00647|   },\n00648| \n00649|   newPatient: {\n00650|     title: 'New Patient Assessment',\n00651|     description: 'Intelligent guided evaluation for ME/CFS, Long COVID, and POTS',\n00652|     demographics: {\n00653|       title: 'Patient Information',\n00654|       description: 'Basic demographics for clinical documentation',\n00655|       step: 'Step 1 of 7: Patient Demographics',\n00656|       age: 'Patient Age',\n00657|       gender: 'Gender',\n00658|       clinicianName: 'Clinician Name',\n00659|       patientId: 'Patient ID/MRN',\n00660|       startAssessment: 'Start Assessment'\n00661|     },\n00662|     progress: {\n00663|       step1: 'Demographics',\n00664|       step2: 'Quick Screen',\n00665|       step3: 'Red Flags',\n00666|       step4: 'Stand Test',\n00667|       step5: 'PEM Quest',\n00668|       step6: 'Criteria',\n00669|       step7: 'Summary'\n00670|     },\n00671|     redFlags: {\n00672|       title: 'Red Flag Assessment',\n00673|       description: 'Check for symptoms requiring urgent evaluation',\n00674|       selectSymptoms: 'Select any symptoms present',\n00675|       continueAssessment: 'Continue Assessment'\n00676|     },\n00677|     standTest: {\n00678|       title: 'Orthostatic Assessment',\n00679|       description: 'Record baseline and standing heart rates',\n00680|       measurements: 'Heart Rate Measurements',\n00681|       measurementDescription: 'Enter heart rate after 5 minutes lying down and peak heart rate within 10 minutes of standing',\n00682|       baselineHR: 'Baseline HR (lying down)',\n00683|       peakHR: 'Peak Standing HR',\n00684|       hrIncrease: 'HR Increase',\n00685|       potsCriteria: 'POTS Criteria (≥30 bpm)',\n00686|       continueToPEM: 'Continue to PEM Assessment'\n00687|     },\n00688|     pemAssessment: {\n00689|       title: 'PEM Assessment',\n00690|       description: 'Post-Exertional Malaise evaluation',\n00691|       finalizeAssessment: 'Finalize Assessment'\n00692|     },\n00693|     processing: {\n00694|       title: 'Processing Diagnostic Criteria...',\n00695|       description: 'Analyzing responses against CDC, NASEM, ESC, and WHO guidelines'\n00696|     },\n00697|     results: {\n00698|       title: 'Patient Assessment Complete',\n00699|       description: 'Comprehensive clinical evaluation with SOAP documentation',\n00700|       primary: 'Primary',\n00701|       noDefinitiveDiagnoses: 'No Definitive Diagnoses: Consider alternative diagnoses, subclinical presentations, or ongoing symptom monitoring. Some patients may benefit from symptomatic treatment while monitoring for progression.',\n00702|       keyResults: 'Key Assessment Results',\n00703|       riskLevel: 'Risk Level',\n00704|       screeningScore: 'Screening Score',\n00705|       pemPresent: 'PEM Present',\n00706|       potsCriteria: 'POTS Criteria',\n00707|       redFlags: 'Red Flags',\n00708|       priority: 'Priority',\n00709|       newAssessment: 'New Assessment',\n00710|       downloadSOAP: 'Download SOAP Note'\n00711|     }\n00712|   },\n00713| \n00714|   conditions: {\n00715|     mecfs: {\n00716|       name: 'ME/CFS',\n00717|       fullName: 'Myalgic Encephalomyelitis/Chronic Fatigue Syndrome',\n00718|       icdCode: 'G93.32',\n00719|       criteria: [\n00720|         'Substantial fatigue not relieved by rest',\n00721|         'Post-exertional malaise',\n00722|         'Unrefreshing sleep',\n00723|         'Cognitive impairment or orthostatic intolerance'\n00724|       ]\n00725|     },\n00726|     longCovid: {\n00727|       name: 'Long COVID',\n00728|       fullName: 'Post-acute sequelae of SARS-CoV-2',\n00729|       icdCode: 'U09.9',\n00730|       criteria: [\n00731|         'COVID-19 infection history',\n00732|         'Symptoms ≥3 months duration',\n00733|         'Multi-system involvement',\n00734|         'Functional impairment'\n00735|       ]\n00736|     },\n00737|     pots: {\n00738|       name: 'POTS',\n00739|       fullName: 'Postural Orthostatic Tachycardia Syndrome',\n00740|       icdCode: 'I47.1',\n00741|       criteria: [\n00742|         'HR increase ≥30 bpm on standing',\n00743|         'Orthostatic symptoms',\n00744|         'Chronic duration ≥3 months',\n00745|         'No orthostatic hypotension'\n00746|       ]\n00747|     }\n00748|   },\n00749| \n00750|   languages: {\n00751|     en: 'English',\n00752|     nl: 'Nederlands',\n00753|     da: 'Dansk',\n00754|     de: 'Deutsch',\n00755|     sv: 'Svenska',\n00756|     no: 'Norsk',\n00757|     fr: 'Français'\n00758|   },\n00759| \n00760|   disclaimer: 'This screening tool is for clinical decision support only and does not replace professional medical judgment'\n00761| }\n</file>",
    "metadata": {
      "preview": "import { Translation } from './types'\n\nexport const en: Translation = {\n  app: {\n    title: 'AutoDx: ME/CFS · Long COVID · POTS',\n    subtitle: 'A guided, guideline-based diagnostic engine and decision support tool for clinicians treating patients with fatigue, dizziness, brain-fog, or palpitations.',\n    tagline: 'Making invisible diseases visible - with evidence, empathy and code.',\n    backToDashboard: 'Back to Dashboard'\n  },\n\n  common: {\n    yes: 'Yes',\n    no: 'No',\n    next: 'Next',\n    previous: 'Previous',\n    continue: 'Continue',\n    complete: 'Complete',\n    cancel: 'Cancel',\n    save: 'Save',\n    download: 'Download',"
    },
    "title": "lib/translations/en.ts",
    "time": {
      "start": 1758131237806,
      "end": 1758131237809
    }
  }
}